Exomics and immunogenics
Anti-PD-1/PD-L1 antibodies are emerging as promising anticancer therapeutics. Interestingly, elevated response rates to these agents are mostly documented among patients with tu...
Publications
View AllAffiliated Researchers
Institution Info
- Type
- company
- Country
- DE
- Publications
- 1
- Citations
- 187
External Links
Identifiers
- ROR
- https://ror.org/01nqn2b57